Acuta Capital Partners, LLC Accelerate Diagnostics, Inc Transaction History
Acuta Capital Partners, LLC
- $92.9 Million
- Q2 2024
A detailed history of Acuta Capital Partners, LLC transactions in Accelerate Diagnostics, Inc stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 50,000 shares of AXDX stock, worth $96,500. This represents 0.19% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$96,500% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AXDX
# of Institutions
3Shares Held
549KCall Options Held
0Put Options Held
0About Accelerate Diagnostics, Inc
- Ticker AXDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 99,059,904
- Market Cap $191M
- Description
- Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...